drugset / Trial / NCT03134443
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis
RandomizedParallel-groupSingle-blindTreatment
Summary
A multicenter, randomized, single-blind, placebo-controlled,phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute tonsillitis
Timeline
- Start
- 2016-12-01
- Primary completion
- 2017-12-31
- Completion
- 2018-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | andrographolide sulfonate | Unknown | 10 ml | Intravenous |
| Comparator | andrographolide sulfonate | Unknown | 20 ml | Intravenous |